All in-person attendees will be required to show proof of vaccination against COVID-19 in order to enter the Salk Institute. Proof includes your vaccination card or a photocopy.
The 17th Annual Peptide Therapeutics Symposium will be held in a hybrid format on October 20th and 21st, 2022. An interactive poster session will be held each day. Registrants will have access to recorded presentations following the close of the meeting.
Hiroaki Suga, The University of Tokyo
Alan Saghatelian, The Salk Institute of Biological Studies
Samir Mitragotri, Havard University
Patsy MacDonald, Moffit Cancer Center
Yuan Cheng, Amgen Inc.
Jan Jezek, Arecor Therapeutics
Monika Papworth, AstraZeneca
Abbas Walji, Merck
Anette Scheemann, Scripps Research
Catharina Svanborg, Lund University
Dafydd Owen, Pfizer Inc.
A special session in recognition of Richard DiMarchi:
Soumitra Ghosh, Doon Assoicates
John Mayer, University of Colorado
Brian Finan, NovoNordisk
Richard DiMarchi, Indiana University
Peptide Therapeutic Foundation
October 20-21, 2022